These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33019728)

  • 1. The Relationship between Leptin, the Leptin Receptor and FGFR1 in Primary Human Breast Tumors.
    Boothby-Shoemaker W; Benham V; Paithankar S; Shankar R; Chen B; Bernard JJ
    Cells; 2020 Oct; 9(10):. PubMed ID: 33019728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
    Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
    Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells.
    Chi F; Griffiths JI; Nath A; Bild AH
    Breast Cancer Res; 2024 Mar; 26(1):54. PubMed ID: 38553760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
    Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
    Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?
    Massabeau C; Sigal-Zafrani B; Belin L; Savignoni A; Richardson M; Kirova YM; Cohen-Jonathan-Moyal E; Mégnin-Chanet F; Hall J; Fourquet A
    Breast Cancer Res Treat; 2012 Jul; 134(1):259-66. PubMed ID: 22438050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin and its receptor are overexpressed in breast cancer tissue of postmenopausal Mexican-Mestizo women with obesity.
    Cárdenas Cárdenas E; Tenorio-Torres A; Méndez JP; Orozco-Arguelles L; Leal-García M; Coral-Vázquez RM; Vega-García CC; Bautista-Piña V; Canto P
    Ann Diagn Pathol; 2022 Oct; 60():151705. PubMed ID: 33685748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.
    Alshaker H; Krell J; Frampton AE; Waxman J; Blyuss O; Zaikin A; Winkler M; Stebbing J; Yagüe E; Pchejetski D
    Breast Cancer Res; 2014 Oct; 16(5):426. PubMed ID: 25482303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 11. FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
    Wellberg EA; Kabos P; Gillen AE; Jacobsen BM; Brechbuhl HM; Johnson SJ; Rudolph MC; Edgerton SM; Thor AD; Anderson SM; Elias A; Zhou XK; Iyengar NM; Morrow M; Falcone DJ; El-Hely O; Dannenberg AJ; Sartorius CA; MacLean PS
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Human Serum Samples to Study Malignant Transformation: A Pilot Study.
    Holowatyj AN; Gigic B; Warby CA; Ose J; Lin T; Schrotz-King P; Ulrich CM; Bernard JJ
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization of leptin and leptin receptor in breast cancer detected in an electron microscopic study.
    Al-Shibli SM; Amjad NM; Al-Kubaisi MK; Mizan S
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1102-1106. PubMed ID: 27914811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth.
    Tarkkonen KM; Nilsson EM; Kähkönen TE; Dey JH; Heikkilä JE; Tuomela JM; Liu Q; Hynes NE; Härkönen PL
    PLoS One; 2012; 7(11):e49970. PubMed ID: 23185502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.
    Turner N; Pearson A; Sharpe R; Lambros M; Geyer F; Lopez-Garcia MA; Natrajan R; Marchio C; Iorns E; Mackay A; Gillett C; Grigoriadis A; Tutt A; Reis-Filho JS; Ashworth A
    Cancer Res; 2010 Mar; 70(5):2085-94. PubMed ID: 20179196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
    Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
    Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater Body Fatness Is Associated With Higher Protein Expression of LEPR in Breast Tumor Tissues: A Cross-Sectional Analysis in the Women's Circle of Health Study.
    Llanos AAM; Aremu JB; Cheng TD; Chen W; Chekmareva MA; Cespedes Feliciano EM; Qin B; Lin Y; Omene C; Khoury T; Hong CC; Yao S; Ambrosone CB; Bandera EV; Demissie K
    Front Endocrinol (Lausanne); 2022; 13():879164. PubMed ID: 35846306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
    Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM
    Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.
    Tomiguchi M; Yamamoto Y; Yamamoto-Ibusuki M; Goto-Yamaguchi L; Fujiki Y; Fujiwara S; Sueta A; Hayashi M; Takeshita T; Inao T; Iwase H
    Cancer Sci; 2016 Apr; 107(4):491-8. PubMed ID: 26801869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor receptor 1 protein (FGFR1) as potential prognostic and predictive marker in patients with luminal B breast cancers overexpressing human epidermal receptor 2 protein (HER2).
    Amina B; Lynda AK; Sonia S; Adel B; Jelloul BH; Miloud M; Tewfik S
    Indian J Pathol Microbiol; 2021; 64(2):254-260. PubMed ID: 33851617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.